Generic Drugs

How are Medicare plans lowering drug costs for beneficiaries?

April 9, 2024 - Affordable access to prescription drugs is a necessity for managing chronic and acute conditions and staying healthy. However, as drug costs rise, both affordability and accessibility are dwindling. Over 80 percent of surveyed adults said the cost of prescription drugs is unreasonable, according to 2023 KFF data. Younger individuals who made less money and took four or more medications...


More Articles

AHIP Argues In Favor of the Copay Coupon Accumulator Rule

by Kelsey Waddill

AHIP submitted an amicus brief in favor of the HHS copay coupon accumulator rule, which would allow states to decide whether pharmaceutical manufacturers’ copay coupons should contribute to...

National Alliance Playbook Guides Employers on Biosimilar Adoption

by Kelsey Waddill

The National Alliance of Healthcare Purchaser Coalitions (National Alliance) has announced the publication of its playbook which aims to encourage biosimilar adoption among employers. “If...

Out-of-Pocket Healthcare Spending for Generics Rose from 2011-2019

by Kelsey Waddill

While negotiated drug prices dropped, out-of-pocket healthcare spending on generic prescription drugs increased for patients as generics moved from Tier 1 to tiers typically dedicated to brand drugs,...

US Drug Pricing Outstrips International Levels, Drives Spending

by Kelsey Waddill

Prescription drug spending in the US drives healthcare spending primarily due to high US drug pricing, not necessarily because of the number of drugs that providers prescribe use, a Commonwealth Fund...

Top Strategies For Driving Down Prescription Drug Spending

by Kelsey Waddill

High prescription drug spending has racked the American healthcare system’s cost trends for decades. Prescription drug spending will be one of the major factors influencing the 2020 medical...